Introduction {#s1}
============

Peak oxygen uptake (*V*′~O~2~peak~) represents the functional limit of the body\'s ability to deliver and extract oxygen in muscles in order to satisfy the metabolic demands of vigorous exercise; it is recognised as the best expression of aerobic fitness \[[@C1]\]. *V*′~O~2~peak~ is increasingly utilised to optimise risk stratification and to facilitate clinical decision making because it reflects therapeutic response and predicts adverse events such as post-operative complications and mortality after abdominal and thoracic surgery \[[@C2]--[@C5]\].

For the interpretation of a cardiopulmonary exercise test (CPET), it is essential to have accurate *V*′~O~2~peak~ reference values corresponding with the ergometer used \[[@C7], [@C8]\]. These values are region or country specific, and change over time due to cultural differences and evolving population characteristics \[[@C8], [@C9]\]. Therefore, each country must have specific updated *V*′~O~2~peak~ reference values that optimally reflect the characteristics of the current population tested, the equipment and the methodology utilised \[[@C8]--[@C10]\]. Although multiple countries provided up-to-date *V*′~O~2~peak~ reference values derived from large cohorts exceeding 4000 participants \[[@C11]--[@C13]\], *V*′~O~2~peak~ reference values from 1985 are the most commonly used in clinical settings in the Netherlands as there are none available derived for the Dutch adult population \[[@C14]\]. These commonly used *V*′~O~2~peak~ reference value prediction equations were obtained from a relatively small sample of 100 participants from the North American population \[[@C14]\].

*V*′~O~2~peak~ is highly influenced by underlying biological ageing processes such as physical development, pubertal status, age-induced neuromuscular deterioration, sarcopenia and cardiopulmonary decline \[[@C7], [@C15], [@C16]\]. It has been hypothesised in both the paediatric and adult populations that *V*′~O~2~peak~ develops in a nonlinear and interrelated manner with the progression of age \[[@C7], [@C17]--[@C20]\]. Linear regression models are predominantly used to determine *V*′~O~2~peak~ reference value prediction equations depending upon sex, age, height, weight and physical activity levels \[[@C9], [@C14], [@C16], [@C21]\].

The frequently used age stratification between the paediatric and adult populations is somewhat arbitrary, and it introduces a discontinuity at the transition point between the two equations, which leads to a reference value shift from the paediatric to the adult population. Additionally, such an age stratification implies more prediction uncertainty as accuracy is lowest at the boundary of the sample age scale. Estimation of an up-to-date general prediction model across the paediatric as well as the adult population would facilitate a smooth transition into adult care. Therefore, the aim of this study is to determine the best-fitting regression model for *V*′~O~2~peak~ in the healthy Dutch paediatric and adult populations in relation to age.

Methods {#s2}
=======

This retrospective multicentre study was conducted using the LowLands Fitness Registry \[[@C6]\], a primary dataset of 8900 subjects from 11 healthcare centres in the Netherlands that was aggregated with the aim of establishing CPET reference values for the Dutch population. Additionally, to determine the external and predictive validity of the reference value prediction model, a cross-validation procedure was performed on an independent sample as recommended by the American Thoracic Society/American College of Chest Physicians (ATS/ACCP) \[[@C8]\]. Specifically, the cross-validation in this study was performed against an additional dataset obtained from the Diving Medical Center (Den Helder, The Netherlands) and the Wilhelmina Children\'s Hospital (Utrecht, The Netherlands). The cross-validation dataset contained 4536 subjects that were not included in the primary dataset. Both datasets contain incremental CPET measurements collected between January 2010 and December 2016. Institutes that were included satisfied the following criteria: 1) to meet the ATS/ACCP statement equipment requirements to perform an incremental CPET using an electromagnetically braked cycle ergometry test utilising gas exchange analysis by bag collection, mixing chamber or breath-by-breath analysis based upon averaging the values measured during the last 30--60 s of the test \[[@C8]\] and 2) to perform equipment quality control in accordance with the ATS/ACCP statement \[[@C8]\].

Subjects included in both datasets underwent an individualised incremental CPET cycle ergometry test for multiple reasons, including: initiated by a healthcare professional, work- and sports-related (mandatory) annual health checks, participation in scientific studies or based on personal motivation (*e.g.* an exercise response evaluation for the aid of a training scheme). Every institute provided anonymised, coded patient information to the data coordinator at the University Medical Center Utrecht (Utrecht, The Netherlands). All records were previously screened for measurement failures. If there were any uncertainties, the testing institute was contacted to ensure the communication of correct data. It has been confirmed by the medical ethical research committee of the University Medical Center Utrecht that the Dutch Medical Research Involving Human Subjects (WMO) Act does not apply to the current study.

Study sample {#s2a}
------------

All of the subjects included in the study were Dutch residents, aged ≤65 years. The status "healthy" was defined as the absence of any reported somatic signs of disease and the exclusion of registered available risk factors \[[@C22]\]. Therefore, subjects were excluded if they reported somatic diseases at the time of testing or showed ECG irregularities prior to testing. Additionally, subjects were excluded from further analysis if they included a missing predictor or outcome values. To ensure subjects reached their maximal measurement (*i.e. V*′~O~2~peak~), subjects were excluded if they did not reach a respiratory exchange peak ratio of at least 1.0 \[[@C23]\] or did not reach a minimum of 85% of the age-predicted maximum heart rate (beats·min^−1^) determined as 208−(0.7×age) \[[@C24]\]. Furthermore, due to the abnormal working capacity and cardiovascular responses to exercise in underweight patients and the recognition of obesity as a disease by the World Health Organization, subjects who had a body mass index (BMI) ≥30 kg·m^−2^ \[[@C25]\] or, in adult subjects, ≤18.5 kg·m^−2^ \[[@C26]\] were excluded. Due to the decrease in *V*′~O~2~peak~ associated with smoking, subjects who actively smoked at the time of the test were excluded \[[@C27]\]. Lastly, professional athletes were excluded because they were considered as not representative for the average Dutch population due to the positive effects of exercise training on *V*′~O~2~peak~ \[[@C28]\]. The exclusion criteria were applied in both the primary and cross-validation datasets.

Statistical analyses {#s2b}
--------------------

Statistical analyses were performed using R version 3.4.4 \[[@C29]\]. A p-value ≤0.05 was considered significant. Continuous data were summarised as mean with standard deviation and categorical data as frequencies (percentage). The variables sex, age, weight and height were included in the analyses as these are commonly used as a basis for *V*′~O~2~peak~ reference value prediction equations \[[@C9]\].

Generalised additive models (GAMs) were utilised to semiparametrically find the most appropriate fitting regression model \[[@C30], [@C31]\]. To determine the model best fitting the data, criteria such as the adjusted R^2^, Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) were used \[[@C32], [@C33]\]. A higher adjusted R^2^ and a lower AIC and BIC were considered as improving the fit. In cases of inconsistency between these, the BIC criterion was taken as the most decisive. The interpretation of the BIC score was: 0--2 as "minimal" improvement, 2--6 as "positive" improvement, 6--10 as "strong" improvement and \>10 as "very strong" improvement \[[@C34]\].

All models fitted to the data included an age by sex interaction term to account for the different *V*′~O~2~peak~ levels between male and female subjects \[[@C11]\]. In order to compare with a best-performing polynomial regression model, each predictive variable was modelled using linear, quadratic and cubic effects by stepwise minimum BIC procedures \[[@C35]\]. The resulting model was employed to represent the polynomial model type in the model fitting procedures. Additionally, based upon the hypothesised nonlinear age dynamics for *V*′~O~2~peak~, an additive model with a smooth spline type of transformation for age was included \[[@C17]--[@C20], [@C31]\].

To determine the fit of the models in the separate paediatric and adult populations, the predictive accuracy of the models was measured using stratified age groups by comparing the residual standard error of the estimate ([see]{.smallcaps}). The groups were stratified by ≤20 and \>20 years of age. The better the predictive fit of either of the three types of models, the less variability there is and the smaller the standard error of the estimate \[[@C36]\].

Models are of little clinical value unless these have predictive accuracy for independent samples. A cross-validation procedure was performed using each identified model per type (linear, polynomial and GAM) against a cross-validation dataset. Similar to criteria for the primary analysis, the model performance was evaluated by a larger adjusted R^2^ and a smaller standard error of the estimate.

For the purpose of illustration, examples of *V*′~O~2~peak~ predictions are reported using the best-performing regression model. For these examples, cases with an increase of 5 years per paediatric case and 10 years per adult case are used; corresponding average height and weight were used determined by data provided by Statistics Netherlands ([www.cbs.nl](https://www.cbs.nl)). The 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th and 97.5th prediction percentile intervals are reported.

Results {#s3}
=======

The complete registry consisted of 8900 cases (1641 females); after applying the exclusion criteria for missing values (n=2674), nonmaximal tests (n=480), BMI ≥30 kg·m^−2^ or, in adults, ≤18.5 kg·m^−2^ (n=324), smokers (n=881) and professional athletes (n=64), a sample of 4477 cases labelled as "healthy" remained (907 females) with age ranging from 7.9 to 65.0 years. The cross-validation sample contained 4536 subjects; after applying the exclusion criteria for missing values (n=0), nonmaximal tests (n=64), BMI ≥30 kg·m^−2^ or, in adults, ≤18.5 kg·m^−2^ (n=260), smoking (n=694) and professional athletes (n=0), a sample of 3518 subjects (170 females) with an age range from 6.8 to 59.0 years remained. [Table 1](#TB1){ref-type="table"} summarises the characteristics of both samples. [Figure 1](#F1){ref-type="fig"} shows the age distribution of the primary sample.

###### 

Sample characteristics

                **Primary sample**   **Cross-validation sample**                                                                                 
  ------------ -------------------- ----------------------------- ----------- ----------- ---------- ------ ----------- ----------- ------------ ----------
  **Female**           907                    32.2±12.8            64.3±11.8   168.6±9.3   22.5±3.0   170    23.0±9.8    61.5±14.5   166.6±12.5   21.8±3.4
  **Male**             3570                   34.6±11.5            81.6±11.6   181.7±8.1   24.6±2.6   3348   33.9±10.0   84.3±11.6   182.7±8.2    25.1±2.4
  **All**              4477                   34.1±11.8            78.1±13.6   179.1±9.9   24.2±2.9   3518   33.4±10.2   83.2±12.7   182.0±9.1    25.0±2.6

Data are presented as n or mean±[sd]{.smallcaps}.

![Age distribution of the primary sample.](00056-2018.01){#F1}

The best-performing polynomial regression model that was found *via* stepwise minimum BIC was: *V*′~O~2~peak~ (mL·min^−1^)= −1469+(673.00×sex)+(16.87×age)+(−0.47×age^2^)+(0.07×height^2^)+(39.70×weight)+(−0.16×weight^2^) (adjusted R^2^=0.56, AIC=69 480.15, BIC=69 531.40), where male=1 and female=0, age is in years, height is in centimetres, and weight is in kilograms.

[Table 2](#TB2){ref-type="table"} summarises various estimated models and their fit measures. The best-fitting model to the dataset was the additive model that includes a smooth spline transformation for age and an interaction term between age and sex plus linear terms for weight and height. The fit of the model yields an adjusted R^2^=0.57, AIC=69 342.81 and BIC=69 449.50. This additive model demonstrates "very strong" improvements \[[@C34]\] compared with both the linear model (BIC difference=170.34) and the polynomial model (BIC difference=81.9). The age-dependent transformations of *V*′~O~2~peak~ are shown in [figure 2](#F2){ref-type="fig"}. Additionally, the linear dependencies of weight and length are shown in [figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}.

###### 

Fitting comparison by regression model type

                          **Estimate**   **Standard error**   **T-value**   **p-value**   **Adjusted R^2^**    **AIC**     **BIC**
  ---------------------- -------------- -------------------- ------------- ------------- ------------------- ----------- -----------
  **Linear model**                                                                                                       
   Intercept                −3039.01           206.02           −14.75        \<0.001           0.55          69 581.40   69 619.84
   Sex                       634.32            25.75             24.63        \<0.001                                    
   Age                       −16.50             0.79            −20.66        \<0.001                                    
   Height                    29.22              1.46             19.95        \<0.001                                    
   Weight                    16.17              1.11             14.48        \<0.001                                    
  **Polynomial model**                                                                                                   
   Intercept                −1469.00           158.80            −9.25        \<0.001           0.56          69 480.15   69 531.40
   Sex                       673.00            25.89             25.99        \<0.001                                    
   Age                       16.87              4.81             3.50         \<0.001                                    
   Age^2^                    −0.47              0.06             −7.31        \<0.001                                    
   Height^2^                  0.07             \<0.01            16.52        \<0.001                                    
   Weight                    39.70              5.17             7.67         \<0.001                                    
   Weight^2^                 −0.16              0.03             −5.05        \<0.001                                    
  **Additive model**                                                                                                     
   Intercept                −2537.29           224.98           −11.28        \<0.001           0.57          69 342.81   69 449.50
   Sex                       743.35            26.30             28.26        \<0.001                                    
   Height                    24.30              1.52             15.91        \<0.001                                    
   Weight                    12.57              1.12             11.21        \<0.001                                    
   S(age): male            4.263^\#^          5.260^¶^         22.59^+^       \<0.001                                    
   S(age): female          7.391^\#^          8.288^¶^         70.38^+^       \<0.001                                    

AIC: Akaike Information Criterion; BIC: Bayesian Information Criterion; S(age): spline function for age per sex. Sex: 0=female, 1=male; age=years; height=centimetres; weight=kilograms. ^\#^: effective degrees of freedom; ^¶^: reference number of degrees of freedom; ^+^: F-value.

![Age-dependent transformation of mean peak oxygen uptake (*V*′~O~2~peak~). Shading represents the pointwise 95% confidence interval.](00056-2018.02){#F2}

![Relationship between mean peak oxygen uptake (*V*′~O~2~peak~) and weight. Shading represents the pointwise 95% confidence interval.](00056-2018.03){#F3}

![Relationship between mean peak oxygen uptake (*V*′~O~2~peak~) and height. Shading represents the pointwise 95% confidence interval.](00056-2018.04){#F4}

The fit of the models compared in the combined and separate paediatric and adult populations is shown in [table 3](#TB3){ref-type="table"}. The additive model provides the largest predictive accuracy overall with an adjusted R^2^=0.57 and [see]{.smallcaps}=556.50 mL·min^−1^ in the entire primary sample; the polynomial and the additive models performed equally against the cross-validation sample, specifically R^2^=0.57 compared with the linear model with R^2^=0.55. Additionally, the additive model also provided the smallest standard error of the estimate in the stratified age groups in both samples, *i.e.* [see]{.smallcaps}=495.18 and 420.72 mL·min^−1^ in those ≤20 years old and [see]{.smallcaps}=563.82 and 476.92 mL·min^−1^ in those \>20 years old. The largest improvement between models in both samples occurred in the ≤20-year-old age group. In this age group, the additive model has a better fit than both the linear and polynomial models, with an equal adjusted R^2^ difference=0.05. Similar improvements are discerned in the standard error of the estimate between the additive and the linear and polynomial models of [see]{.smallcaps}=65.47 and 53.62 mL·min^−1^ in the primary sample and [see]{.smallcaps}=108.14 and 35.81 mL·min^−1^ in the cross-validation sample, respectively.

###### 

Fit of model type per age group and sample set

  **Model and age group**    **Primary sample**   **Cross-validation sample**         
  ------------------------- -------------------- ----------------------------- ------ --------
  **Linear model**                                                                    
   All                              0.55                    572.89              0.54   487.84
   ≤20 years                        0.71                    560.65              0.81   528.86
   \>20 years                       0.50                    574.43              0.37   484.56
  **Polynomial model**                                                                
   All                              0.56                    566.20              0.57   476.72
   ≤20 years                        0.71                    548.80              0.82   456.03
   \>20 years                       0.51                    568.37              0.38   478.26
  **Additive model**                                                                  
   All                              0.57                    556.50              0.57   473.15
   ≤20 years                        0.76                    495.18              0.84   420.72
   \>20 years                       0.52                    563.82              0.38   476.92

[see]{.smallcaps}: standard error of the estimate.

Reference values with corresponding prediction intervals are constructed using average weight and height per sex and age provided by Statistics Netherlands. [Table 4](#TB4){ref-type="table"} shows the predictions for the female cases and [table 5](#TB5){ref-type="table"} shows the predictions for the male cases. In both sexes, the 2.5th and 97.5th prediction interval in the 60-year-old cases is the largest: 352 mL·min^−1^ for the female cases and 213 mL·min^−1^ for the male cases. The 2.5th and 97.5th prediction interval of the 30-year-old cases is the smallest: 131 and 78 mL·min^−1^, respectively. Both sexes have increasing *V*′~O~2~peak~ prediction until the age of 20 years followed by a decline.

###### 

Additive model peak oxygen uptake (*V*′~O~2~peak~) prediction percentiles: female cases

   **Age decile years**   **Height cm**   **Weight kg**   ***V*′**~**O~2~peak**~ **mL·min^−1^ prediction percentile**                                                   
  ---------------------- --------------- --------------- ------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------
          **10**              143.0           33.5                                   1581                               1601   1624   1662   1704   1746   1784   1807   1826
          **15**              164.0           52.0                                   2345                               2359   2375   2401   2429   2458   2484   2500   2513
          **20**              168.8           63.2                                   2543                               2556   2570   2593   2619   2645   2668   2682   2694
          **30**              169.3           68.5                                   2415                               2426   2438   2458   2481   2503   2523   2536   2546
          **40**              169.3           70.3                                   2298                               2309   2322   2343   2367   2391   2412   2425   2436
          **50**              167.7           70.5                                   2089                               2104   2120   2148   2180   2211   2239   2255   2270
          **60**              166.6           71.6                                   1793                               1821   1854   1908   1969   2029   2084   2117   2145

###### 

Additive model peak oxygen uptake (*V*′~O~2~peak~) prediction percentiles: male cases

  **Age decile years**    **Height cm**   **Weight kg**   ***V*′**~**O~2~peak**~ **mL·min^−1^ prediction percentile**                                                   
  ---------------------- --------------- --------------- ------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------
  **10**                      143.0           34.0                                   1329                               1351   1377   1421   1469   1518   1561   1587   1610
  **15**                      168.0           53.0                                   2775                               2788   2804   2831   2860   2889   2916   2932   2945
  **20**                      183.5           78.1                                   3808                               3816   3825   3841   3858   3875   3891   3900   3908
  **30**                      183.7           83.3                                   3818                               3825   3832   3844   3857   3870   3882   3889   3896
  **40**                      182.4           85.1                                   3718                               3725   3733   3747   3763   3778   3792   3800   3808
  **50**                      181.3           86.4                                   3292                               3301   3311   3327   3346   3364   3381   3391   3399
  **60**                      179.2           84.4                                   2969                               2986   3006   3039   3076   3112   3145   3165   3182

Discussion {#s4}
==========

The aim of this study was to determine reference values for *V*′~O~2~peak~ based upon an optimal regression model in healthy Dutch paediatric and adult populations. Based on adjusted R^2^, AIC, BIC and standard error of the estimate, the additive model was the best fitting with the largest predictive accuracy. From the model, it can be concluded that *V*′~O~2~peak~ is sex specific and depends nonlinearly on years of age.

We determined that the additive model results in a smaller standard error of the estimate especially in the ≤20-year-old subjects because, in contrast to the linear model, the additive model is able to adjust for age-related transformations such as the increase in *V*′~O~2~peak~ associated with the growth-related weight and height gain during childhood and adolescence. The increase in skeletal muscle mass during this life phase accounts for the majority of weight gained \[[@C37]\]. As skeletal muscle mass is responsible for the majority of oxygen utilised during exercise, the increase in skeletal muscle mass associated with increasing age in ≤20-year-old subjects partially explains the increase in *V*′~O~2~peak~ during this life phase \[[@C38]\]. During adulthood, the increase in skeletal muscle mass and height are limited. *V*′~O~2~peak~ decreases during adulthood because of a decrease in muscle mass and a loss of chronotropic competence \[[@C24], [@C39]\].

Our additive regression model differs from previously utilised linear and polynomial regression models \[[@C9], [@C40], [@C41]\]. The use of the advanced statistical analysis method, GAM, in the current study makes it possible to determine the best-fitting regression model for the combined paediatric and adult populations. This method fits the data through cubic-type splines with the degree of smoothness determined by generalised cross-validation, which facilitates combining the previously hypothesised nonlinear and interrelated fashion of more than one independent variable in the paediatric and adolescent populations, and the curvilinear decline with age in the adult population \[[@C7], [@C17]--[@C20]\]. This method results in an improved fit across the entire population \[[@C17], [@C18], [@C20]\]. Therefore, prediction of *V*′~O~2~peak~ in the transition group between adolescents and adulthood is more precise when using the additive model.

In comparison with the prediction models currently utilised in the Dutch clinical settings, the additive model improves the fit in both the adult and paediatric populations. The linear prediction model for adults provided by J[ones]{.smallcaps} *et al*. \[[@C14]\] yields R^2^=0.41 to the primary sample and R^2^=0.33 to the cross-validation sample compared with R^2^=0.52 and 0.38, respectively, in the additive model. The linear prediction equation provided by T[en]{.smallcaps} H[arkel]{.smallcaps} *et al*. \[[@C41]\] is most frequently used in the Dutch paediatric population, this equation yields R^2^=0.58 and 0.73 compared with R^2^=0.76 and 0.84 in the primary and cross-validation sample, respectively. These improved fits make the additive model provided by the current study a more adequate reference prediction equation to utilise in both the paediatric and adult populations.

Primary sample analysis and cross-validation showed consistent results, specifically a stronger predictive accuracy in ≤20-year-old subjects, and accuracy improvement in \>20-year-old subjects and the entire sample. This consistent increase in predictive accuracy indicates a good generalisability to the Dutch population. This is underlined by the fit of R^2^=0.54 ([see]{.smallcaps}=556.55 mL·min^−1^) of the additive model to the whole sample, including smokers, all BMI values and athletes. The somewhat lower adjusted R^2^ of the additive model obtained in the cross-validation \>20-year-old subgroup suggests a difference from the primary sample analysis. This is possibly caused by the use of a variety of more institutions providing \>20-year-old subjects in the cross-validation sample. Every subject \>20 years old in this sample was tested at a single institute aimed at test indications such as sport- and work-related (mandatory) annual health checks. The underrepresentation of tests initiated by a healthcare professional results in a cross-validation sample with higher aerobic fitness compared with the more heterogeneous primary sample (healthy workers effect).

The strength of our study is the wide age range of 7.9--65.0 years. The LowLands Fitness Registry that we used in our study is a reasonable representation of the Dutch population. Additionally, the utilisation of a diverse variety of healthcare centres, including hospitals, sports medicine clinics and occupational medicine clinics, ensures representation of every conditioning status. The familiarity of the Dutch population with cycling and the low risk of injury during testing ensures this method of measurement is fitting for the population and participants of all ages \[[@C8]\].

Study results are limited by the retrospective and institution-based nature of the study. Preferably, *V*′~O~2~peak~ reference value research should be performed using a prospective community-based method \[[@C8]\], since a retrospective study design has potential data quality issues. Although every institution used measurement methods and equipment described by the ACCP/ATS statement \[[@C8]\], the exclusion of 4364 subjects emphasises the variety of data quality in the primary sample. The majority of excluded subjects were due to missing values, accounting for 2674 excluded subjects. It is of primary importance that CPET instructors increase their skills and knowledge, and stringently apply the test guidelines provided by the ATS/ACCP statement in order to facilitate data harmonisation \[[@C8]\].

Representative reference *V*′~O~2~peak~ values are genuinely needed because of the current lack of reference data in the Dutch population. The currently employed North American reference values from 1985 may plausibly underestimate the aerobic fitness for the Dutch population; hence, subjects are misclassified as having normal aerobic fitness. The additive regression equation presented in the current study can be used to determine a reference value for the Dutch population. In future research aimed at determining reference value prediction equations, the type of regression model fitted to the data may be conveniently modelled by semiparametric regression. This research can best be performed in a prospective, community-based setting with emphasis on the inclusion of sufficient numbers of female participants.

Conclusion {#s4a}
----------

In conclusion, this study has provided a robust additive regression model for *V*′~O~2~peak~ in the Dutch population. *V*′~O~2~peak~ is sex specific and has a nonlinear relationship with age. Publicly usable reference values can be conveniently obtained by suitable software implementation.
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